Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 1
Submit an article Journal homepage
121
Views
12
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: Promising results in marginal zone lymphoma

Theofanis Economopoulos Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece
,
Amanda Psyrri Second Department of Internal Medicine, Attikon University Hospital, Athens, GreeceCorrespondence[email protected]
,
George Fountzilas Department of Medicinal Oncology, Papageorgiou University Hospital, Thessaloniki, Greece
,
Constantinos Tsatalas Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece
,
Athanasios Anagnostopoulos Department of Clinical Therapeutics, Alexandra University Hospital, Athens, Greece
,
Sotirios Papageorgiou Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece
,
Nikolaos Xiros Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece
&
Meletios Athanasios Dimopoulos Department of Clinical Therapeutics, Alexandra University Hospital, Athens, Greece
 show all
Pages 68-74 | Received 22 May 2007, Accepted 02 Nov 2007, Published online: 01 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Magda Migkou, Meletios-Athanassios Dimopoulos, Maria Gavriatopoulou & Evangelos Terpos. (2009) Applications of monoclonal antibodies for the treatment of hematological malignancies. Expert Opinion on Biological Therapy 9:2, pages 207-220.
Read now

Articles from other publishers (11)

Dominic Kaddu-Mulindwa, Lorenz Thurner, Konstantinos Christofyllakis, Moritz Bewarder & Igor Age Kos. (2022) Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives. Cancers 14:12, pages 3019.
Crossref
Francesco Bertoni, Davide Rossi, Markus Raderer & Emanuele Zucca. (2020) Marginal Zone Lymphomas. The Cancer Journal 26:4, pages 336-347.
Crossref
Sigrid Cherrier-De Wilde. 2018. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 267 276 .
Barbara KiesewetterAndrés J.M. Ferreri & Markus Raderer. (2015) Chemoimmunotherapy for Mucosa‐Associated Lymphoid Tissue‐Type Lymphoma: A Review of the Literature. The Oncologist 20:8, pages 915-925.
Crossref
Sigrid Cherrier-De Wilde. 2013. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 447 457 .
Harinder Gill, Chor-Sang Chim, Wing-Yan Au, Florence Loong, Eric Tse, Anskar Y. H. Leung & Yok-Lam Kwong. (2011) Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results. Annals of Hematology 90:12, pages 1399-1407.
Crossref
Steven I. ParkJaideep ShenoiJohn M. PagelDon K. HamlinD. Scott WilburNural OrgunAimee L. KenoyerShani FrayoAmanda AxtmanTom Bäck, Yukang LinDarrell R. Fisher, Ajay K. GopalDamian J. GreenOliver W. Press. (2010) Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease. Blood 116:20, pages 4231-4239.
Crossref
Franck Morschhauser, Martin Dreyling, Ama Rohatiner, Fredrick Hagemeister & Angelika Bischof Delaloye. (2009) Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin’s Lymphoma: A Review of the Evidence. The Oncologist 14:S2, pages 17-29.
Crossref
Stefan Peinert, Dennis Carney, H. Miles Prince, E. Henry Januszewicz & John F. Seymour. (2009) Fludarabine combinations for patients with advanced marginal zone lymphomas - best treatment option or too toxic?. British Journal of Haematology 146:6, pages 685-686.
Crossref
Lev ShvidelMirel CohnErica Sigler. (2009) Pharmacotherapy Update: Fludarabine in the Treatment of Non-Hodgkin's Lymphoma. Clinical Medicine. Therapeutics 1, pages CMT.S2553.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:3, pages 184-191.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.